Clinical Trial Update: The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of hUC mesenchymal stem cells (iSCLife®-OA) for osteoarthritis of the knee; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• iSCLife®-OA (hUC Mesenchymal Stem Cell Therapy) (human umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: RECRUITING